DOI QR코드

DOI QR Code

Identification of Novel Compound Heterozygous Mutations in the ACADS Gene of an Asymptomatic Korean Newborn with Short Chain Acyl-CoA Dehydrogenase Deficiency by Tandem Mass Spectrometry

  • Cheon, Chong-Kun (Department of Pediatrics, College of Medicine, Medical Research Institute, Pusan National University, Children's Hospital) ;
  • Choi, Hyung-Soon (Department of Pediatrics, Kosin University Gospel Hospital) ;
  • Kim, Su-Yung (Department of Pediatrics, College of Medicine, Medical Research Institute, Pusan National University, Children's Hospital) ;
  • Yoo, Han-Wook (Department of Medical Genetics Clinic and Laboratory, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Gu-Hwan (Department of Medical Genetics Clinic and Laboratory, Asan Medical Center, University of Ulsan College of Medicine)
  • Received : 2012.06.07
  • Accepted : 2012.06.21
  • Published : 2012.06.30

Abstract

Short-chain acyl-CoA dehydrogenase deficiency (SCADD; OMIM # 201470) is an autosomal recessive inborn error of mitochondrial fatty acid ${\beta}$-oxidation, presenting with a variety of clinical signs and symptoms. Developmental delay, hypertonia or hypotonia, ketotic hypoglycemia, and epilepsy are most frequently reported. In general, patients diagnosed through newborn screening have shown normal growth and development in contrast to those diagnosed as a result of clinically initiated evaluations. Here, the case of an asymptomatic Korean newborn with SCADD identified by tandem mass spectrometry is reported. The patient showed an elevated concentration of butyrylcarnitine detected on newborn screening. Urinary excretion of ethylmalonic acid was elevated by urine organic acid analysis. To confirm the diagnosis of SCADD, a direct sequencing analysis of 10 coding exons and the exon-intron boundaries of the ACADS gene were performed. Genetic analysis of ACADS showed the following novel compound heterozygous missense mutations: c.277C>A (p.Leu93Ile) on exon3 and c.682G>A (p.Glu288Lys) on exon6. These results will provide further evidence of mutational heterogeneity for SCADD.

Keywords

References

  1. van Maldegem BT, Duran M, Wanders RJ, Waterham HR, Wijburg FA. Flavin adenine dinucleotide status and the effects of high-dose riboflavin treatment in short-chain acyl-CoA dehydrogenase deficiency. Pediatr Res 2010;67:304-8. https://doi.org/10.1203/PDR.0b013e3181cbd57b
  2. van Maldegem BT, Wanders RJ, Wijburg FA. Clinical aspects of shortchain acyl-CoA dehydrogenase deficiency. J Inherit Metab Dis 2010; 33:507-11.
  3. Bok LA, Vreken P, Wijburg FA, Wanders RJ, Gregersen N, Corydon MJ, et al. Short-chain Acyl-CoA dehydrogenase deficiency: studies in a large family adding to the complexity of the disorder. Pediatrics 2003; 112:1152-5. https://doi.org/10.1542/peds.112.5.1152
  4. Jethva R, Bennett MJ, Vockley J. Short-chain acyl-coenzyme A dehydrogenase deficiency. Mol Genet Metab 2008;95:195-200. https://doi.org/10.1016/j.ymgme.2008.09.007
  5. Moczulski D, Majak I, Mamczur D. An overview of beta-oxidation disorders. Postepy Hig Med Dosw (Online) 2009;63:266-77.
  6. Schmidt SP, Corydon TJ, Pedersen CB, Vang S, Palmfeldt J, Stenbroen V. Toxic response caused by a misfolding variant of the mitochondrial protein short-chain acyl-CoA dehydrogenase. J Inherit Metab Dis 2011; 34:465-75. https://doi.org/10.1007/s10545-010-9255-7
  7. Shirao K, Okada S, Tajima G, Tsumura M, Hara K, Yasunaga S. Molecular pathogenesis of a novel mutation, G108D, in short-chain acyl-CoA dehydrogenase identified in subjects with short-chain acyl- CoA dehydrogenase deficiency. Hum Genet 2010;127:619-28. https://doi.org/10.1007/s00439-010-0822-7
  8. Pedersen CB, Kolvraa S, Kølvraa A, Stenbroen V, Kjeldsen M, Ensenauer R, et al. The ACADS gene variation spectrum in 114 patients with short-chain acyl-CoA dehydrogenase (SCAD) deficiency is dominated by missense variations leading to protein misfolding at the cellular level. Hum Genet 2008;124:43-56. https://doi.org/10.1007/s00439-008-0521-9
  9. Waisbren SE, Levy HL, Noble M, Matern D, Gregersen N, Pasley K, et al. Short-chain acyl-CoA dehydrogenase (SCAD) deficiency: an examination of the medical and neurodevelopmental characteristics of 14 cases identified through newborn screening or clinical symptoms. Mol Genet Metab 2008;95:39-45. https://doi.org/10.1016/j.ymgme.2008.06.002
  10. Lindner M, Hoffmann GF, Matern D. Newborn screening for disorders of fatty-acid oxidation: experience and recommendations from an expert meeting. J Inherit Metab Dis 2010;33:521-6. https://doi.org/10.1007/s10545-010-9076-8
  11. Sewell AC, Herwig J, Bohles H, Rinaldo P, Bhala A, Hale DE. A new case of short-chain acyl-CoA dehydrogenase deficiency with isolated ethylmalonic aciduria. Eur J Pediatr 1993;152:922-4. https://doi.org/10.1007/BF01957531
  12. Zolkipli Z, Pedersen CB, Lamhonwah AM, Gregersen N, Tein I. Vulner ability to oxidative stress in vitro in pathophysiology of mitochondrial short-chain acyl-CoA dehydrogenase deficiency: response to antioxidants. PLoS One 2011;6:e17534. https://doi.org/10.1371/journal.pone.0017534
  13. Mikati MA, Chaaban HR, Karam PE, Krishnamoorthy KS. Brain malformation and infantile spasms in a SCAD deficiency patient. Pediatr Neurol 2007;36:48-50. https://doi.org/10.1016/j.pediatrneurol.2006.08.008
  14. van Maldegem BT, Duran M, Wanders RJ, Niezen-Koning KE, Hogeveen M, Ijlst L, et al. Clinical, biochemical, and genetic heterogeneity in short-chain acyl-coenzyme A dehydrogenase deficiency. JAMA 2006;296:943-52. https://doi.org/10.1001/jama.296.8.943
  15. Gregersen N, Andresen BS, Corydon MJ, Corydon TJ, Olsen RK, Bolund L, et al. Mutation analysis in mitochondrial fatty acid oxidation defects: Exemplified by acyl-CoA dehydrogenase deficiencies, with special focus on genotype-phenotype relationship. Hum Mutat 2001;18:169-89. https://doi.org/10.1002/humu.1174
  16. Kim SH, Park HD, Sohn YB, Park SW, Cho SY, Ji S, et al, Mutations of ACADS gene associated with short-chain acyl-coenzyme A dehydrogenase deficiency. Ann Clin Lab Sci 2011;41:84-8.